A-Alpha Bio vs LabGenius Therapeutics
A-Alpha Bio
The protein-protein interaction company
50 employees · est. 2017 · Seattle, United States
LabGenius Therapeutics
Combining human and machine intelligence to discover the next generation of therapeutic antibodies
63 employees · est. 2012 · London, United Kingdom
LabGenius Therapeutics is the older company (2017 vs 2012); LabGenius Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | A-Alpha Bio | LabGenius Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2012 older |
| Headquarters | ||
| Headquarters | Seattle, United States | London, United Kingdom |
| Employees | ||
| Employees | 50 | 63 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | AI, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $60.78M | $63.66M |
| Funding Rounds | ||
| Funding Rounds | 8 | 6 |
| Services | ||
| Services | Quantitative Characterization of Protein Interactions, Machine Learning Model Development for Biology, Platform for Drug Discovery and Optimization | Therapeutic Antibody Discovery, Multispecific Antibody Development, AI and Machine Learning Integration |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Healthcare Organizations | Pharmaceutical Companies, Biotech Research Organizations, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | Protein-Protein InteractionsAlphaSeq TechnologyAlphaBind AI PlatformBiotechnology PlatformDrug DiscoveryProtein Engineering +9 | Therapeutic AntibodiesDrug DiscoveryRobotic AutomationSynthetic BiologyProtein TherapeuticsAntibody Engineering +6 |
| Website | ||
| Website | aalphabio.com | labgeniustx.com |
About A-Alpha Bio
A-Alpha Bio, known as "The protein-protein interaction company," is a pioneering entity in the biotechnology industry focused on the large-scale measurement, prediction, and engineering of protein-protein interactions. Founded in 2017 and based in the United States, this innovative company utilizes...
About LabGenius Therapeutics
LabGenius Therapeutics, founded in 2012, is a drug discovery company based in the United Kingdom. It focuses on the development of next-generation therapeutic antibodies utilizing its advanced EVA™ platform, which combines artificial intelligence, robotic automation, and synthetic biology. This plat...
Also comparing in this category
Comparing more than these two?
Get A-Alpha Bio, LabGenius Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does A-Alpha Bio compare?
A PDF of A-Alpha Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare A-Alpha Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at A-Alpha Bio on 7 Nov 2026, and LabGenius Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
